1Jonsson CA,Svensson L,Carlsten H. Beneficial effect of the inosine rnonophosp hate dehydrogenase inhibitor my cophenolate rnofetil on survival and severity of glornerulonephrit is in systemic lupus erythe rnatosus(SLE)-prone MRL lpr/lpr rnice[J]. Clin Exp Immunol, 1999,116 (3):534-541.
1Austin HA. Therapy of lupus nephritis: controlled trial of prednisone and cytoxic drugs. New Engl J Med, 1986, 314:614-619.
2Vasquez S, Kavanaugh AF, Schneider NR, et al. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol,1992, 19: 1625.
3Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis, 1998, 32: 318-322.
4Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med, 2000,343: 1156-1162.
